Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20171225038070N1
IRCT20171225038070N1
Completed
Phase 3

Comparison of the efficacy of oxybutynin and phenazopyridine and celecoxib with placebo in the treatment of urinary tract symptoms after BCG therapy in bladder tumors patients

Iran University of Medical Sciences0 sites120 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMalignant neoplasm of bladder.Malignant neoplasm of bladder

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Malignant neoplasm of bladder.
Sponsor
Iran University of Medical Sciences
Enrollment
120
Status
Completed
Last Updated
7 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •bladder cancer
  • •candidates for BCG therapy
  • •Non muscle bladder cancer

Exclusion Criteria

  • •history of pelvic surgery
  • •severe urinary tract symptoms (IPSS over 20\)
  • •overactive bladder
  • •complete urinary incontinence
  • •traumatic catheterization
  • •active TB symptoms

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
A randomised trial comparing the effectiveness of oxybutynin and mirabegron in reducing symptoms of frequency and urgency in patients with benign prostatic hyperplasia receiving medical treatment with tamsulosin.Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
CTRI/2019/10/021513JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION RESEARCH96
Completed
Phase 4
Comparison of the Effectiveness of 10% Oxybutynin Topical Gel and 20% Aluminum Chloride in Patients with Primary Hyperhidrosis: a Randomized Double-Blind Controlled Trial
IRCT20221110056463N2Kerman University of Medical Sciences30
Completed
N/A
A comparative study between treatment with oxybutynin and botulinum toxin type A in patients with neurogenic detrusor overactivity
ISRCTN56769820Dr Henrique Santillo Rehabilitation Center (Brazil)68
Recruiting
Phase 4
to compare combination of Buprenorphine-naloxone with moxonidine versus clonidine in opioid detoxificatioHealth Condition 1: F112- Opioid dependence
CTRI/2022/07/043760Govt Medical College Rajindra Hospital Patiala
Completed
N/A
Evaluation of the efficacy of oxybutynin and imipramine in the management of detrusor instabilityIncontinenceUrological and Genital Diseases
ISRCTN58226681Medical Research Council (MRC) (UK)345